Her research has been instrumental in establishing the clinical profile of next-generation metabolic therapies and advancing understanding of multi-receptor agonist approaches to obesity treatment
As of 2026, no large-scale, peer-reviewed Phase IIII clinical trials of BPC-157 in humans have been published in major medical journals
GHK-Cu also exhibits antioxidant and anti-inflammatory effects, protecting tissues from oxidative damage and reducing inflammation, which accelerates healing and tissue repair
Each batch undergoes analytical verification to ensure high purity and consistency for reliable experimental outcomes
LipoStat-Plus (Lipo Plus) LipoStat-Plus is formulated for active individuals who want to optimize their energy levels and physical performance
It delivers copper to lysyl oxidase, the enzyme responsible for cross-linking collagen types I and III into durable, organized fibers